Tjitske Duiveman‐de Boer

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Gerty Schreibelt, Kalijn F. Bol, Harm Westdorp et al. · Clinical Cancer Research · 2015 · 235 citations · Full text

Medicine, Immunology, Oncology +17

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines

Ghaith Bakdash, Sonja I. Buschow, Mark A.J. Gorris et al. · Cancer Research · 2016 · 112 citations · Full text

Medicine, Immunology, Oncology +17

Human CD1c⁺ DCs are critical cellular mediators of immune responses induced by immunogenic cell death

Stefania Di Blasio, Inge M. N. Wortel, Diede A.G. van Bladel et al. · OncoImmunology · 2016 · 102 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

Erik H.J.G. Aarntzen, Gerty Schreibelt, Kalijn F. Bol et al. · Clinical Cancer Research · 2012 · 98 citations

Medicine, Immunology, Oncology +17

Intratumoral rhIL‐12 administration in head and neck squamous cell carcinoma patients induces B cell activation

Carla M.L. van Herpen, Robbert van der Voort, Jeroen van der Laak et al. · International Journal of Cancer · 2008 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17